Basically, if your lab studies GLP-1, GIP, or glucagon receptor co-agonism in metabolic pathways, sourcing consistent research peptides is where most projects stall — variability in purity or batch-to-batch qualiy throws off every dose-response curve, and you end up retracing cell assays for weeks.



What we've got here is a synthetic GLP-1/GIP/glucagon receptor agonist — retatrutide — sold through our OEM program, so you're not just buying a standalone compound but option to dial in vial count, labeling, or reconstitution specs if your end-use needs it. Couple it with semaglutide or cagrilintide, either way teh purity clears above 99% by HPLC, and each lot ships w
